Medical Corporation Retirement Benefit Schemes: Optimizing Tax Burden Through Executive Retirement Pay During M&A

In medical corporation M&A, the payment of retirement benefits to directors and executives is a key strategy for optimizing tax burdens through income dispersion and achieving smooth business succession. Specifically, by paying executive retirement benefits at the time of M&A, it is possible to reduce the individual income tax burden while also expecting a reduction in corporate tax burden through deductible expenses for the corporation. However, without a thorough understanding of how to calculate retirement pay, payment methods, and tax audit risks, one may face unexpected tax issues. This article provides a detailed explanation of executive retirement benefit schemes in medical corporation M&A, covering their advantages and disadvantages, appropriate calculation methods, tax audit countermeasures, and specific procedures, in line with search intent. We offer practical information to achieve smooth business succession and optimize tax burdens.

Purpose of Executive Retirement Benefit Payments and Benefits in M&A

In medical corporation M&A, the payment of retirement benefits to directors and executives is positioned not merely as compensation for retirement but as a strategic tax and business succession measure. The main objectives are as follows:

• Reduced Tax Burden Through Income Dispersion: Lump-sum payments received as M&A consideration can incur high taxes as individual income. By paying these as executive retirement benefits, the retirement income deduction applies, significantly reducing the tax burden. Furthermore, since retirement income is taxed separately, it is less affected by progressive taxation when combined with other income.
• Reduced Corporate Tax Burden: Executive retirement benefits are generally deductible as expenses for the corporation. This reduces the corporation’s taxable income, leading to a lower corporate tax burden. The ability to treat large fund transfers associated with M&A as deductible expenses is a significant benefit for the corporation.
• Smooth Transfer of Management Rights: Paying retirement benefits as compensation for long-term service upon the retirement of a director or executive is important for facilitating a smooth resignation and transfer of management control.
• Adjustment of M&A Consideration: Depending on the M&A structure, a portion of the sale consideration can be paid as executive retirement benefits to adjust the overall tax burden.

Method for Calculating Appropriate Executive Retirement Benefits

The amount of executive retirement benefits must be calculated with extreme caution to avoid disallowance during tax audits. Generally, the appropriateness as “compensation for meritorious service” is determined by considering the following factors:

Basic Calculation Factors

1. Period of Service: The length of service is an important factor in calculating retirement benefits.
2. Position/Title: The weight of the position, such as chairman, and the degree of responsibility are considered.
3. Merits/Contributions: The extent of contribution to the corporation’s development and specific achievements are evaluated.
4. Retirement Benefit Levels of Similar Corporations: The prevailing market rates are understood by referencing examples of executive retirement benefits paid by medical corporations of similar size and industry.
5. Corporation’s Performance and Financial Status: The corporation’s business performance and ability to pay are also taken into account.

Example Calculation Method (General Guideline)

The most commonly used formula is “Base Salary (Executive Remuneration) × Years of Service × Merit Multiplier.” However, this is merely a guideline, and adjustments are necessary based on individual circumstances.

• Base Salary: Monthly or annual executive remuneration.
• Years of Service: The period served as chairman or executive.
• Merit Multiplier: This is often set between 1.0 and 3.0 times, depending on the position and contributions, but can be higher for exceptional achievements. However, setting an excessively high multiplier increases tax risks.

For example, with a monthly remuneration of 1 million yen, 20 years of service, and a merit multiplier of 1.5, the retirement benefit would be 1,000,000 yen × 12 months × 20 years × 1.5 = 360 million yen. Whether this amount is appropriate is determined by comprehensively considering the levels of similar corporations and the corporation’s situation, as mentioned above.

Executive Retirement Benefit Payment Schemes and Tax Treatment

There are several options for paying executive retirement benefits, each with different tax implications. It is necessary to consider which scheme is optimal for payment at the time of M&A.

Main Payment Schemes

1. Payment Simultaneously with M&A Execution: This is a case where retirement benefits are paid in a lump sum, either as part of the M&A consideration or at the time of M&A execution. This allows for reduction of individual income tax burden while also being deductible for the corporation.
2. Executive Resignation Before M&A Execution and Retirement Benefit Payment: This scheme involves the director/executive resigning before the M&A execution, receiving retirement benefits, and then proceeding with the M&A. This clearly defines the period for treatment as retirement income.
3. Payment After a Certain Period Following M&A Execution: This applies when executives continue their roles after M&A execution but a retirement date is set, and retirement benefits are paid at that time.

Tax Treatment (Individual/Corporation)

Taxpayer	Tax Treatment	Key Points
Individual (Recipient)	Taxed as Retirement Income	The retirement income deduction (calculated based on years of service) applies, significantly reducing the tax burden. Since it is taxed separately from other income, it is less affected by progressive taxation.
Corporation (Payer)	Deductible as an Expense	Executive retirement benefits are generally deductible as “executive remuneration” for the corporation, thereby reducing corporate tax. However, if the amount is unreasonably high, it may be deemed an “executive bonus” and risk being disallowed as an expense.

Compared to capital gains from stock transfers received as M&A consideration, receiving funds as retirement benefits is often more advantageous for both individuals and corporations from a tax perspective.

Management and Countermeasures for Tax Audit Risks

Executive retirement benefits are one of the items frequently scrutinized during tax audits. Improper payments can lead to additional tax assessments and penalties, necessitating thorough countermeasures.

Points Frequently Raised in Tax Audits

• Unreasonableness of Amount: Retirement benefits that are unreasonably high compared to achievements, period of service, and levels at similar corporations.
• Process of Payment Decision: Cases where the decision was made solely by the representative without formal resolution by the general shareholders’ meeting or board of directors.
• Lack of Clarity on Reason for Payment: Payments made without specific reasons for retirement or contributions, and without clear justification.
• Unnatural Timing of Payment: Payments made immediately before or after M&A, raising suspicion of tax evasion.

Tax Audit Countermeasures

1. Establishment of Retirement Benefit Regulations: It is crucial to have “Executive Retirement Benefit Regulations” in place beforehand, clearly stating the calculation standards, eligibility criteria, and decision-making process for retirement benefits, and to obtain approval from the general shareholders’ meeting or board of directors.
2. Preparation of Objective Documentation: Prepare documentation such as examples of retirement benefits at similar corporations, evidence of the director’s achievements (contributions to regional healthcare, improvements in hospital performance, etc.), and proof of service duration to explain the appropriateness of the retirement benefit amount.
3. Formal Resolution: Ensure that the decision to pay retirement benefits is always resolved at a general shareholders’ meeting or board of directors meeting, and keep minutes of the proceedings.
4. Consultation with Experts: Consulting with experts such as tax accountants and M&A advisors when calculating retirement benefit amounts and designing payment schemes is essential for risk avoidance.

What M&A Medical (CentralMedience) Can Assist With

Medical corporation M&A is a field that requires specialized knowledge and experience. Especially in schemes involving complex tax and legal aspects, such as the payment of retirement benefits to directors and executives, the support of trusted experts is key to success.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, with extensive experience and specialized knowledge in medical corporation M&A. We provide comprehensive support from strategic planning in the initial stages of M&A, through due diligence, contract execution, to post-M&A integration.

Specifically, we support clients with executive retirement benefit schemes in the following areas:

• Support for Calculating Appropriate Retirement Benefit Amounts: We assist in calculating the optimal retirement benefit amount, considering legal compliance, minimization of tax risks, and appropriateness as compensation for meritorious service.
• Scheme Design and Tax/Legal Advice: We propose the most advantageous plan for positioning executive retirement benefit payments within the overall M&A scheme, in collaboration with tax and legal experts.
• Advice on Tax Audit Countermeasures: We provide concrete advice on necessary documentation and preparation for explanations, anticipating potential tax audit risks in advance.
• Support for Smooth Negotiations and Execution: Our team of experts fully supports coordination among stakeholders and the execution of complex procedures.

Medical corporation directors and executives who wish to achieve successful business succession through M&A and optimize their tax burden are encouraged to consult with M&A Medical.

Obtain an Estimate Instantly with a Free Simple Assessment

Frequently Asked Questions (FAQ)

Q1. How should M&A consideration and executive retirement benefits be differentiated?

A1. M&A consideration (e.g., stock transfer) is subject to comprehensive taxation as capital gains, tending to result in a higher tax burden. On the other hand, executive retirement benefits are eligible for the retirement income deduction and are taxed separately, thus reducing the tax burden. It is important to optimize the allocation between consideration and retirement benefits based on the M&A structure and individual circumstances. We recommend consulting with experts to determine the most advantageous allocation ratio.

Q2. When is the most tax-advantageous time to pay executive retirement benefits?

A2. Generally, paying retirement benefits at the time of executive resignation is the easiest way to clearly process them as retirement income. This can include cases where resignation and retirement benefit payment occur simultaneously with M&A execution, or where resignation and retirement benefit payment are completed before M&A execution. Depending on the timing of payment, there is a risk of disallowance during tax audits, so it is crucial to determine the optimal timing in consultation with an expert.

Q3. Can I receive a larger retirement benefit by setting a higher merit multiplier?

A3. Setting a higher merit multiplier will increase the calculated retirement benefit amount. However, if an unreasonably high multiplier is set, it may be deemed to exceed the appropriateness as “compensation for meritorious service” during a tax audit, and risk being treated as an executive bonus, thus disallowed as an expense. It is extremely important to set the multiplier within an objectively reasonable range, considering the retirement benefit levels of similar corporations, specific achievements, and the corporation’s performance.

Q4. If my medical corporation is acquired in an M&A, will the current retirement benefit regulations be inherited?

A4. This depends on the M&A structure and the acquiring party’s intentions. Generally, the acquiring party will establish new retirement benefit regulations or abolish/amend existing ones. However, in some M&A agreements, it may be agreed to maintain the existing retirement benefit regulations for a certain period, or for the acquiring party to assume the obligation to pay retirement benefits. It is important to clarify the arrangements regarding retirement benefits during the M&A negotiation phase.

Q5. Are there other ways to reduce the tax burden during M&A besides executive retirement benefits?

A5. Yes, by structuring the M&A itself, it may be possible to reduce the tax burden. For example, choosing an asset transfer over a stock transfer, receiving consideration through installment payments, establishing a holding company, or utilizing business succession tax systems are possibilities. Additionally, it is possible to combine executive retirement benefits with other forms of compensation (paid separately as merit bonuses or lump sums) at the time of M&A. All these methods require specialized knowledge, so please consult with an M&A advisor or tax accountant.

📊 FREE ASSESSMENT

Free Simple Assessment in 1 Minute / 3 Questions

Receive an estimate of your medical institution’s transfer price instantly.
Strictly confidential, no sales calls, receive report via email.

Start Free Simple Assessment →